| 1.9 |
5.6 |
GO:0060929 |
Purkinje myocyte differentiation(GO:0003168) septum secundum development(GO:0003285) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 1.4 |
4.3 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 1.3 |
8.0 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 1.2 |
3.7 |
GO:0050894 |
determination of affect(GO:0050894) |
| 1.0 |
3.1 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.0 |
3.0 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.9 |
2.8 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.9 |
2.8 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.9 |
2.7 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.9 |
2.6 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.8 |
2.4 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.8 |
2.3 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.7 |
2.1 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.7 |
2.0 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.6 |
1.9 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.6 |
6.8 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.6 |
2.5 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.6 |
1.2 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) |
| 0.6 |
2.3 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.6 |
2.3 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.6 |
2.2 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.5 |
2.2 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.5 |
3.2 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.5 |
2.0 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.5 |
1.0 |
GO:0061053 |
somite development(GO:0061053) |
| 0.5 |
2.4 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.5 |
5.7 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.5 |
1.9 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.5 |
3.3 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.5 |
2.8 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.5 |
2.3 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.5 |
1.4 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.5 |
1.4 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.4 |
1.3 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.4 |
1.3 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.4 |
2.2 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.4 |
1.3 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.4 |
1.7 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.4 |
1.3 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.4 |
1.3 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.4 |
5.0 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.4 |
1.2 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.4 |
1.6 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.4 |
1.2 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.4 |
4.1 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.4 |
2.0 |
GO:2000691 |
regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.4 |
2.0 |
GO:1904448 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.4 |
1.2 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.4 |
1.2 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.4 |
1.2 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.4 |
1.2 |
GO:0042414 |
catechol-containing compound biosynthetic process(GO:0009713) epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) catecholamine biosynthetic process(GO:0042423) |
| 0.4 |
2.7 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.4 |
2.3 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.4 |
0.4 |
GO:0010658 |
striated muscle cell apoptotic process(GO:0010658) |
| 0.4 |
1.9 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.4 |
0.8 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.4 |
1.1 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.4 |
1.1 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.4 |
3.0 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.4 |
1.1 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.4 |
0.4 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.4 |
0.4 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.4 |
1.1 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 |
1.7 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.3 |
1.0 |
GO:0061075 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.3 |
1.7 |
GO:0043462 |
regulation of ATPase activity(GO:0043462) |
| 0.3 |
0.7 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 |
2.0 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 |
0.7 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.3 |
0.3 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.3 |
0.7 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 |
1.7 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.3 |
1.0 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.3 |
6.3 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 |
1.0 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.3 |
1.0 |
GO:0019082 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.3 |
2.0 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 |
0.7 |
GO:0022406 |
membrane docking(GO:0022406) |
| 0.3 |
1.6 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.3 |
2.3 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.3 |
1.3 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.3 |
1.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.3 |
0.6 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.3 |
0.3 |
GO:0003193 |
pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.3 |
1.3 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.3 |
0.3 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.3 |
3.8 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.3 |
4.7 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.3 |
0.3 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.3 |
9.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.3 |
0.3 |
GO:1903747 |
regulation of establishment of protein localization to mitochondrion(GO:1903747) |
| 0.3 |
5.9 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.3 |
4.3 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.3 |
0.3 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.3 |
0.9 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.3 |
1.2 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.3 |
0.9 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.3 |
0.9 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.3 |
0.9 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.3 |
0.9 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.3 |
0.6 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.3 |
1.2 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.3 |
3.5 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.3 |
2.9 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.3 |
0.3 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.3 |
2.0 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.3 |
0.8 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.3 |
2.2 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.3 |
0.8 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.3 |
6.0 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.3 |
1.6 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.3 |
2.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.3 |
1.9 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.3 |
0.8 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.3 |
1.1 |
GO:1901624 |
negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.3 |
0.3 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.3 |
0.8 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.3 |
1.8 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.3 |
1.5 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
1.5 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.3 |
0.8 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.3 |
0.5 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.3 |
0.8 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.3 |
0.8 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.3 |
2.5 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.3 |
2.5 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.3 |
0.8 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.3 |
1.8 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.3 |
1.3 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.3 |
2.0 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.3 |
0.3 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 |
1.0 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.2 |
0.7 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.2 |
0.2 |
GO:0060323 |
head morphogenesis(GO:0060323) |
| 0.2 |
0.7 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.2 |
0.5 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.2 |
0.2 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.2 |
1.0 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 |
0.2 |
GO:1904882 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.2 |
1.0 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.2 |
0.2 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.2 |
1.2 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 |
0.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.2 |
2.4 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.2 |
0.7 |
GO:0046081 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.2 |
0.7 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.2 |
1.9 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.2 |
0.5 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.2 |
0.7 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.2 |
0.7 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.2 |
1.6 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 |
4.2 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.2 |
3.0 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 |
3.0 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.2 |
0.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
1.1 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.2 |
5.5 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.2 |
2.0 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.2 |
2.7 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 |
0.9 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.2 |
2.2 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.2 |
2.9 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.2 |
2.2 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.2 |
1.3 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
0.9 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 |
0.9 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 0.2 |
1.3 |
GO:0061188 |
negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 |
0.9 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.2 |
0.6 |
GO:0071262 |
regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.2 |
1.1 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 |
1.7 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.2 |
0.4 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.2 |
1.1 |
GO:0009183 |
purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.2 |
0.6 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.2 |
1.1 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.2 |
1.1 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.2 |
0.6 |
GO:0032752 |
positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.2 |
3.4 |
GO:1904869 |
regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.2 |
0.4 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.2 |
1.7 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
0.2 |
GO:0021898 |
commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.2 |
4.0 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 |
0.4 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.2 |
0.4 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 |
1.0 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.2 |
0.6 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.2 |
3.9 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.2 |
0.8 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.2 |
0.6 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
0.2 |
GO:0030318 |
melanocyte differentiation(GO:0030318) |
| 0.2 |
0.6 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.2 |
1.6 |
GO:0045007 |
depurination(GO:0045007) |
| 0.2 |
0.6 |
GO:0070376 |
regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.2 |
0.2 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.2 |
0.6 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.2 |
1.4 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.2 |
1.0 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.2 |
1.6 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
0.6 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.2 |
0.6 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.2 |
0.4 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 |
0.8 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.2 |
1.2 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.2 |
0.2 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.2 |
0.6 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.2 |
0.6 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.2 |
1.0 |
GO:1990869 |
response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.2 |
0.6 |
GO:1902910 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.2 |
0.6 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.2 |
1.3 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.2 |
0.4 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
0.4 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.2 |
0.8 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.2 |
0.6 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.2 |
0.6 |
GO:1905064 |
negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 0.2 |
0.6 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.2 |
0.6 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 |
0.9 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.2 |
0.9 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.2 |
0.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.2 |
0.6 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.2 |
0.7 |
GO:0051167 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.2 |
0.7 |
GO:0052214 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.2 |
0.9 |
GO:1903597 |
negative regulation of gap junction assembly(GO:1903597) |
| 0.2 |
0.6 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.2 |
0.6 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.2 |
2.4 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 |
1.6 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.2 |
0.7 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
0.2 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
5.2 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.2 |
0.2 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.2 |
7.9 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.2 |
0.2 |
GO:1990034 |
calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.2 |
0.5 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.2 |
0.5 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.2 |
1.8 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.2 |
0.7 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 |
1.1 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.2 |
0.7 |
GO:0061324 |
glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.2 |
0.2 |
GO:1900086 |
positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.2 |
3.0 |
GO:0009755 |
hormone-mediated signaling pathway(GO:0009755) |
| 0.2 |
1.2 |
GO:0090063 |
positive regulation of microtubule nucleation(GO:0090063) |
| 0.2 |
3.7 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
0.7 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 |
0.2 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.2 |
1.4 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.2 |
0.2 |
GO:0051466 |
positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.2 |
0.5 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.2 |
0.2 |
GO:0033014 |
tetrapyrrole biosynthetic process(GO:0033014) |
| 0.2 |
0.2 |
GO:0060411 |
cardiac septum morphogenesis(GO:0060411) |
| 0.2 |
0.7 |
GO:1990926 |
vesicle-mediated cholesterol transport(GO:0090119) short-term synaptic potentiation(GO:1990926) |
| 0.2 |
0.3 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.2 |
0.3 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 |
2.1 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.2 |
1.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
1.2 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.2 |
0.8 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 |
0.8 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 |
1.0 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 |
1.5 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 |
1.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.2 |
0.2 |
GO:0048859 |
inhibition of neuroepithelial cell differentiation(GO:0002085) formation of anatomical boundary(GO:0048859) |
| 0.2 |
0.5 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.2 |
0.3 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.2 |
0.5 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.2 |
0.3 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.2 |
0.5 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.2 |
2.0 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.2 |
1.0 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.2 |
0.7 |
GO:1904800 |
regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 |
1.1 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.2 |
0.3 |
GO:0044111 |
development involved in symbiotic interaction(GO:0044111) |
| 0.2 |
1.8 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
1.1 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.2 |
0.3 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.2 |
0.5 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.2 |
0.3 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.2 |
1.0 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 |
3.4 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 |
2.7 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
0.8 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.2 |
1.0 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.2 |
0.2 |
GO:2000583 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.2 |
0.3 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.2 |
0.3 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.2 |
0.8 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
0.3 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.2 |
0.2 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.2 |
1.3 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.2 |
0.5 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
| 0.2 |
0.9 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 |
0.2 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.2 |
0.9 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.2 |
0.5 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.2 |
0.2 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 0.2 |
2.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
0.3 |
GO:0019827 |
stem cell population maintenance(GO:0019827) |
| 0.2 |
0.6 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.2 |
0.5 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) |
| 0.2 |
0.6 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.2 |
1.4 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.1 |
0.7 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
4.3 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
0.4 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.1 |
0.3 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.7 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 |
0.1 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.1 |
1.9 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.1 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.1 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.1 |
0.3 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 |
0.4 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 |
0.9 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.1 |
0.9 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 |
0.6 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
0.7 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.1 |
1.2 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.1 |
1.9 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.1 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
0.4 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.1 |
0.9 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 |
0.3 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.1 |
1.6 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
1.7 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
1.0 |
GO:0021834 |
chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
| 0.1 |
2.4 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
0.3 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.1 |
3.5 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.9 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.1 |
0.4 |
GO:0021697 |
cerebellar cortex formation(GO:0021697) |
| 0.1 |
0.6 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.1 |
1.8 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.8 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.1 |
0.4 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.1 |
0.8 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.1 |
0.4 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.3 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 |
0.4 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
2.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.3 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.7 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
1.0 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.1 |
0.1 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.1 |
0.4 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
0.6 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.1 |
0.6 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 |
0.8 |
GO:0042560 |
folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.1 |
1.0 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.1 |
0.6 |
GO:0071283 |
cellular response to iron(III) ion(GO:0071283) |
| 0.1 |
1.0 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 |
2.6 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
1.8 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.3 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 |
2.8 |
GO:1902373 |
negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
0.5 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.1 |
0.4 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.1 |
4.4 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
0.7 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.1 |
1.3 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 |
0.7 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.4 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.4 |
GO:0038034 |
signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.1 |
2.9 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 |
0.1 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 |
0.5 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.1 |
0.7 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
1.2 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
0.1 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 |
0.1 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.1 |
0.7 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.1 |
0.3 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
1.3 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.1 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
0.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.4 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.1 |
0.6 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.1 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.1 |
0.5 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
0.8 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 |
2.4 |
GO:0071402 |
cellular response to lipoprotein particle stimulus(GO:0071402) |
| 0.1 |
0.1 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.8 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.9 |
GO:0070383 |
DNA cytosine deamination(GO:0070383) |
| 0.1 |
0.6 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.1 |
2.0 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 |
0.3 |
GO:0071806 |
protein transmembrane transport(GO:0071806) |
| 0.1 |
0.5 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.1 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
1.4 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.3 |
GO:0031076 |
embryonic camera-type eye development(GO:0031076) |
| 0.1 |
0.8 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.1 |
0.5 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.1 |
0.9 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.1 |
0.2 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 |
0.4 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.1 |
1.9 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.2 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 |
0.6 |
GO:0070944 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 |
0.5 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.5 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
1.2 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 |
0.6 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 |
0.5 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.1 |
0.5 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
0.2 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
0.1 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 |
0.5 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.1 |
1.8 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 |
5.8 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
1.2 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.5 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.1 |
0.4 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.1 |
0.4 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.6 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.1 |
2.3 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
1.2 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.4 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 |
0.4 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.1 |
0.7 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.1 |
0.2 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 |
0.6 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 |
0.8 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) |
| 0.1 |
0.2 |
GO:0060921 |
sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) |
| 0.1 |
0.5 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.1 |
0.1 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
| 0.1 |
0.9 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.5 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 |
0.6 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 |
0.6 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.1 |
0.7 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 |
0.8 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
3.5 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.2 |
GO:0015874 |
norepinephrine transport(GO:0015874) norepinephrine secretion(GO:0048243) |
| 0.1 |
0.1 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.1 |
0.1 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.1 |
0.3 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.1 |
0.5 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
0.8 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 |
0.5 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 |
0.1 |
GO:0086091 |
regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.1 |
1.4 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
1.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.1 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 |
0.3 |
GO:0042770 |
signal transduction in response to DNA damage(GO:0042770) |
| 0.1 |
0.1 |
GO:1901534 |
positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.1 |
2.9 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.8 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.1 |
0.8 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.1 |
1.2 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.1 |
GO:0060775 |
mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 0.1 |
1.0 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.2 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 0.1 |
2.6 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.6 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.1 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 |
0.6 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.1 |
0.4 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.8 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
1.3 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.1 |
0.3 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.1 |
0.2 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
2.0 |
GO:0045141 |
meiotic telomere clustering(GO:0045141) |
| 0.1 |
0.2 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 |
0.5 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 |
1.0 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.2 |
GO:0036003 |
positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
| 0.1 |
0.1 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 |
1.2 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
3.0 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
1.0 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.5 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.1 |
0.3 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.2 |
GO:0051604 |
protein maturation(GO:0051604) |
| 0.1 |
4.6 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.1 |
0.7 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
0.7 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.2 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.1 |
2.7 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.8 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.6 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.1 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.1 |
0.4 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
0.2 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
2.0 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.3 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.1 |
0.5 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.1 |
1.1 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.1 |
6.9 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.1 |
0.8 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.1 |
0.6 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) |
| 0.1 |
0.7 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
0.5 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
0.7 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
0.5 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
0.5 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
0.4 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.6 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.1 |
0.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
0.7 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 |
0.4 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.1 |
0.8 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 |
0.3 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.1 |
0.4 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 |
0.2 |
GO:0021936 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.1 |
0.8 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.1 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) |
| 0.1 |
0.4 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.1 |
2.6 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 |
0.1 |
GO:1902474 |
regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.4 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.1 |
0.6 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 |
0.2 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
0.4 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.2 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.1 |
0.5 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 |
0.6 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
2.7 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
| 0.1 |
0.4 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
4.0 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.1 |
0.3 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.1 |
0.5 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.8 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.1 |
0.1 |
GO:1902804 |
negative regulation of synaptic vesicle transport(GO:1902804) |
| 0.1 |
2.3 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.2 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.1 |
0.8 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
1.1 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.1 |
0.3 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 |
0.1 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.9 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.1 |
0.5 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
0.3 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.4 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.4 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.4 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.1 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.1 |
0.3 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.8 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.1 |
0.2 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.1 |
0.5 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.3 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.1 |
0.8 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
0.8 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 |
0.1 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 |
4.6 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.1 |
1.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.1 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.1 |
0.3 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.1 |
0.3 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
1.0 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
0.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.3 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.1 |
0.1 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.1 |
0.1 |
GO:0071871 |
response to epinephrine(GO:0071871) |
| 0.1 |
0.9 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.9 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.5 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 |
1.5 |
GO:0060211 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
1.3 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
3.0 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.1 |
0.7 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.3 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.1 |
1.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.2 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.1 |
0.3 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 |
0.3 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.5 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.8 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.1 |
0.4 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 |
0.4 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
1.9 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.9 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.4 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.1 |
0.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.4 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.8 |
GO:0018904 |
ether metabolic process(GO:0018904) |
| 0.1 |
0.4 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
7.0 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.2 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
| 0.1 |
0.2 |
GO:1902229 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
| 0.1 |
0.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.4 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
0.8 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.1 |
0.3 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.1 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
1.4 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 |
0.4 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
1.3 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
0.4 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.1 |
0.1 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.1 |
0.3 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
0.3 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.1 |
0.3 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.1 |
0.3 |
GO:0014038 |
regulation of Schwann cell differentiation(GO:0014038) |
| 0.1 |
2.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
1.5 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.3 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.3 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.1 |
0.6 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.9 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
6.7 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.1 |
0.4 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.1 |
0.2 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.6 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.3 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 |
0.7 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
1.5 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.5 |
GO:0008334 |
histone mRNA metabolic process(GO:0008334) |
| 0.1 |
1.0 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.2 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 |
0.2 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.1 |
1.2 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.2 |
GO:1902080 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.1 |
2.1 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.1 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.6 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 |
0.2 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.3 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
0.6 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.1 |
0.3 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.1 |
1.0 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.4 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.2 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 |
0.2 |
GO:1903533 |
regulation of protein targeting(GO:1903533) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.5 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.5 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.1 |
1.5 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.1 |
1.0 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.5 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 |
4.1 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
0.2 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 |
0.3 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 |
0.3 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.2 |
GO:0021532 |
neural tube patterning(GO:0021532) |
| 0.1 |
0.1 |
GO:2001251 |
negative regulation of chromosome organization(GO:2001251) |
| 0.1 |
0.8 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.3 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.1 |
0.2 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.1 |
0.2 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 |
0.2 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
0.2 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.1 |
0.2 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.1 |
0.4 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.1 |
0.1 |
GO:0051664 |
nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
| 0.1 |
0.4 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 |
0.3 |
GO:0097045 |
phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.1 |
0.2 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 |
0.4 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 |
2.0 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.2 |
GO:0044205 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 |
0.2 |
GO:0032069 |
regulation of nuclease activity(GO:0032069) |
| 0.1 |
0.2 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 |
1.5 |
GO:0060973 |
cell migration involved in heart development(GO:0060973) |
| 0.1 |
0.2 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.4 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 |
0.8 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.2 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.4 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.4 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 |
0.5 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.3 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.2 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 |
0.2 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
0.5 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.1 |
0.2 |
GO:0042747 |
circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.1 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.5 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.1 |
0.3 |
GO:0046487 |
glyoxylate metabolic process(GO:0046487) |
| 0.1 |
1.0 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
1.0 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.1 |
1.0 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.2 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.1 |
0.6 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
0.7 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
0.1 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.1 |
0.5 |
GO:2001212 |
regulation of vasculogenesis(GO:2001212) |
| 0.1 |
11.9 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.1 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.1 |
0.2 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 |
0.2 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
1.4 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.1 |
1.2 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.1 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.1 |
0.2 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.1 |
0.6 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
0.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.6 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.2 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.1 |
0.2 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 |
0.2 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
1.6 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
0.4 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.3 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
0.9 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 |
0.5 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 0.1 |
0.4 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.1 |
0.1 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
0.6 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.9 |
GO:0007626 |
locomotory behavior(GO:0007626) |
| 0.1 |
0.3 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.1 |
0.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
1.4 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.1 |
0.3 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.2 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.7 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 |
7.3 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 |
0.6 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.1 |
0.1 |
GO:0014734 |
skeletal muscle hypertrophy(GO:0014734) |
| 0.1 |
0.3 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.1 |
0.4 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.1 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.1 |
0.9 |
GO:0014870 |
response to muscle inactivity(GO:0014870) |
| 0.1 |
1.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.1 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.1 |
0.3 |
GO:0046203 |
spermidine catabolic process(GO:0046203) |
| 0.1 |
0.7 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.1 |
0.5 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.1 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.1 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
2.1 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
0.3 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
1.9 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.2 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 0.1 |
0.3 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 |
0.3 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 |
0.1 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
1.1 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.2 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.1 |
0.1 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
1.1 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
0.1 |
GO:0032375 |
negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
| 0.1 |
0.4 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 |
1.2 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
0.1 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.1 |
0.2 |
GO:0018194 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 |
0.4 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 |
0.1 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.1 |
0.4 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 |
0.5 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
0.8 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.6 |
GO:0003356 |
regulation of cilium beat frequency(GO:0003356) |
| 0.1 |
0.5 |
GO:0071352 |
interleukin-2-mediated signaling pathway(GO:0038110) cellular response to interleukin-2(GO:0071352) |
| 0.1 |
0.9 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.1 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.1 |
0.4 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
1.5 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.4 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.6 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.3 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 |
0.1 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 |
0.1 |
GO:0071878 |
negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 0.1 |
0.2 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.2 |
GO:0007622 |
rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.6 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
0.1 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.1 |
0.2 |
GO:0032715 |
negative regulation of interleukin-6 production(GO:0032715) |
| 0.1 |
0.2 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.1 |
0.2 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.1 |
0.2 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.5 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.3 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) establishment of mitochondrion localization(GO:0051654) |
| 0.1 |
0.3 |
GO:0072711 |
response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
| 0.1 |
0.2 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 |
0.2 |
GO:0021877 |
forebrain neuron fate commitment(GO:0021877) |
| 0.1 |
0.2 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.1 |
0.2 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.3 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.4 |
GO:0006789 |
bilirubin conjugation(GO:0006789) |
| 0.1 |
0.4 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 |
0.2 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.1 |
0.2 |
GO:0045645 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.1 |
0.6 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 |
0.3 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 |
2.8 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.1 |
0.7 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
0.4 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
0.1 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.1 |
0.1 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 |
0.1 |
GO:0071224 |
cellular response to peptidoglycan(GO:0071224) |
| 0.1 |
1.2 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 |
0.6 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.1 |
0.1 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.1 |
2.4 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
0.4 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.1 |
0.2 |
GO:0072108 |
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
| 0.1 |
0.2 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.2 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 |
0.2 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.1 |
0.9 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.6 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
1.2 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.2 |
GO:0021836 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.1 |
0.2 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.1 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.4 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
1.3 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
0.3 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 |
0.1 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.1 |
0.2 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
0.3 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.5 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.2 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.1 |
0.2 |
GO:0050993 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.1 |
1.9 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.3 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.1 |
0.1 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.1 |
0.2 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 |
1.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.2 |
GO:0051410 |
detoxification of nitrogen compound(GO:0051410) |
| 0.1 |
2.8 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.1 |
0.4 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.1 |
0.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.2 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.1 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
1.2 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.1 |
0.5 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.1 |
0.1 |
GO:0070423 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.1 |
0.1 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.1 |
0.8 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.1 |
0.3 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.2 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.1 |
0.2 |
GO:0070352 |
positive regulation of white fat cell proliferation(GO:0070352) |
| 0.1 |
0.6 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) |
| 0.1 |
0.2 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.1 |
0.1 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.1 |
0.2 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.4 |
GO:0015942 |
formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 |
0.5 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
0.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 |
1.0 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 |
0.3 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 |
0.5 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
1.1 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
4.0 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 |
0.2 |
GO:0071353 |
response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.3 |
GO:0070142 |
synaptic vesicle budding(GO:0070142) |
| 0.1 |
0.3 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 |
2.2 |
GO:0003254 |
regulation of membrane depolarization(GO:0003254) |
| 0.1 |
0.3 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.1 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
0.5 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
2.0 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 |
0.4 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.1 |
1.7 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.1 |
0.2 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.1 |
0.2 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.6 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.1 |
0.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.4 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
| 0.1 |
0.3 |
GO:1901073 |
N-acetylglucosamine biosynthetic process(GO:0006045) amino sugar biosynthetic process(GO:0046349) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.1 |
0.1 |
GO:0007008 |
outer mitochondrial membrane organization(GO:0007008) |
| 0.1 |
0.1 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.1 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.2 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.1 |
0.8 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 |
0.8 |
GO:0090128 |
regulation of synapse maturation(GO:0090128) |
| 0.1 |
0.2 |
GO:0007162 |
negative regulation of cell adhesion(GO:0007162) |
| 0.1 |
0.1 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
0.8 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
0.1 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.1 |
0.4 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.1 |
0.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.1 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.1 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.7 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.7 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.1 |
0.1 |
GO:0042490 |
mechanoreceptor differentiation(GO:0042490) inner ear receptor cell differentiation(GO:0060113) |
| 0.1 |
0.6 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
0.6 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
2.2 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 |
0.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.2 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.0 |
0.3 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.0 |
0.0 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.0 |
0.3 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.0 |
0.2 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.6 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.4 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.0 |
0.1 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.0 |
0.0 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
0.3 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.1 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.0 |
0.9 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
1.2 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.2 |
GO:1905225 |
response to thyrotropin-releasing hormone(GO:1905225) |
| 0.0 |
0.1 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 |
0.1 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.0 |
0.0 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.0 |
0.1 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.0 |
0.3 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.0 |
1.3 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.0 |
1.0 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.2 |
GO:0097191 |
extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.0 |
0.4 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.0 |
0.7 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.0 |
0.3 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.0 |
0.1 |
GO:0044179 |
hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.0 |
0.3 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.2 |
GO:0010998 |
regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
| 0.0 |
0.2 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.0 |
0.8 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.1 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) regulation of histamine secretion by mast cell(GO:1903593) |
| 0.0 |
0.1 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 0.0 |
0.1 |
GO:0043280 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
| 0.0 |
0.1 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
2.1 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 |
0.5 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.2 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.0 |
0.1 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.0 |
2.1 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.0 |
0.2 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.0 |
0.5 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.3 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.0 |
0.5 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.0 |
0.1 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
2.2 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.1 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.0 |
0.3 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.3 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.0 |
0.3 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.0 |
1.0 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.0 |
0.9 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.0 |
0.1 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.0 |
0.1 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.2 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.0 |
0.2 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.0 |
0.1 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.0 |
0.8 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.0 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.0 |
0.4 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.0 |
0.2 |
GO:0071306 |
cellular response to vitamin E(GO:0071306) |
| 0.0 |
0.3 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.0 |
0.2 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.5 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 |
0.3 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.0 |
0.1 |
GO:0002888 |
positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.0 |
0.7 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
0.6 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
1.0 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.2 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.0 |
0.2 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 |
0.9 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.1 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.0 |
0.4 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
1.3 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.6 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.0 |
0.6 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
0.4 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
2.3 |
GO:0072431 |
signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.0 |
0.0 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.0 |
0.1 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.0 |
0.1 |
GO:0071613 |
granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 0.0 |
0.2 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.0 |
0.2 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.0 |
0.5 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.2 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.0 |
0.4 |
GO:0009128 |
purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.0 |
0.3 |
GO:1902033 |
regulation of hematopoietic stem cell proliferation(GO:1902033) |
| 0.0 |
0.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.1 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.0 |
0.1 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.1 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.0 |
0.1 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.0 |
1.0 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.3 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
0.1 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.0 |
0.4 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.0 |
0.1 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.0 |
0.3 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.4 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.5 |
GO:0010310 |
regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.0 |
0.6 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.4 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 |
0.4 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.4 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.0 |
0.5 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.0 |
0.2 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.0 |
0.2 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.0 |
0.2 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.0 |
0.4 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.0 |
0.5 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
4.6 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.5 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.0 |
0.4 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.2 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.2 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.4 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.2 |
GO:0038091 |
VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 0.0 |
1.0 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
1.6 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.1 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.0 |
0.4 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.1 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.0 |
0.5 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.1 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.3 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.0 |
0.1 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.1 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.0 |
0.1 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.0 |
1.9 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.1 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.0 |
1.0 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.0 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
2.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.2 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.0 |
0.1 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.3 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.0 |
0.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.0 |
0.1 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
2.7 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.0 |
0.2 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.0 |
0.3 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.1 |
GO:0070255 |
regulation of mucus secretion(GO:0070255) |
| 0.0 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.3 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.0 |
3.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.0 |
GO:0032228 |
regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.0 |
0.3 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 |
0.1 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.0 |
0.1 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.0 |
1.1 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.1 |
GO:0003164 |
His-Purkinje system development(GO:0003164) Purkinje myocyte development(GO:0003165) |
| 0.0 |
0.0 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.2 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 |
0.1 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.0 |
0.1 |
GO:0002774 |
Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.0 |
0.1 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.0 |
0.1 |
GO:0060838 |
radial pattern formation(GO:0009956) lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.0 |
0.1 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.0 |
0.1 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 |
0.5 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 |
0.9 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.1 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
1.4 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.2 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 |
0.1 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.1 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.0 |
0.2 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.1 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.0 |
0.2 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.1 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.0 |
1.0 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.0 |
0.1 |
GO:0051412 |
response to corticosterone(GO:0051412) |
| 0.0 |
0.6 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.1 |
GO:0051413 |
response to cortisone(GO:0051413) |
| 0.0 |
0.1 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.1 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.0 |
0.1 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.1 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.0 |
0.1 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.0 |
0.3 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 |
0.3 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.3 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.0 |
0.8 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.4 |
GO:0006281 |
DNA repair(GO:0006281) |
| 0.0 |
0.1 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.0 |
0.2 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.1 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.4 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
0.1 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.0 |
4.1 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.1 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.1 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.1 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.0 |
0.1 |
GO:0006294 |
nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.0 |
0.4 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.1 |
GO:0034111 |
negative regulation of homotypic cell-cell adhesion(GO:0034111) |
| 0.0 |
0.3 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.0 |
0.1 |
GO:0002545 |
microglial cell activation involved in immune response(GO:0002282) chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.0 |
0.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.0 |
0.2 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.0 |
0.2 |
GO:1904580 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.0 |
0.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.1 |
GO:0097049 |
motor neuron apoptotic process(GO:0097049) |
| 0.0 |
0.1 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.1 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.0 |
0.7 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.0 |
1.5 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.0 |
0.1 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.0 |
0.3 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.1 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 |
0.0 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 0.0 |
0.1 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.0 |
0.2 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.0 |
0.1 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 0.0 |
0.3 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
0.2 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
| 0.0 |
0.2 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.0 |
0.1 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.0 |
0.1 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.0 |
0.2 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.2 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.1 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 |
1.7 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.1 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
0.1 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.0 |
0.2 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 |
0.1 |
GO:1903727 |
positive regulation of phospholipid metabolic process(GO:1903727) |
| 0.0 |
0.2 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.0 |
0.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.3 |
GO:0030878 |
thyroid gland development(GO:0030878) |
| 0.0 |
0.3 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.1 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.0 |
0.1 |
GO:0046440 |
L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.0 |
0.4 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 |
0.2 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.0 |
2.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.4 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.2 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.3 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.0 |
0.8 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 |
0.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.0 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.0 |
0.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.0 |
0.2 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.2 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 |
0.1 |
GO:1904744 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.0 |
0.2 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.0 |
0.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.0 |
0.6 |
GO:0016071 |
mRNA metabolic process(GO:0016071) |
| 0.0 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.1 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.0 |
1.7 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.2 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 |
0.4 |
GO:1902913 |
regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.0 |
0.2 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.0 |
0.1 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.0 |
0.2 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.0 |
0.1 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.0 |
0.2 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 |
0.4 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.0 |
0.0 |
GO:0071504 |
response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 0.0 |
0.6 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.0 |
2.0 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.2 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
0.1 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.0 |
0.2 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.0 |
0.1 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.0 |
0.1 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.9 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.2 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 |
0.0 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.0 |
0.1 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.0 |
0.4 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 |
0.5 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.0 |
0.1 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.0 |
0.1 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.0 |
0.3 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.4 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.2 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.0 |
0.1 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.0 |
0.2 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.0 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.0 |
0.1 |
GO:0070972 |
protein localization to endoplasmic reticulum(GO:0070972) |
| 0.0 |
0.2 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.1 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.0 |
0.2 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.0 |
0.1 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.0 |
0.0 |
GO:0051584 |
regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
| 0.0 |
0.2 |
GO:0051928 |
positive regulation of calcium ion transport(GO:0051928) |
| 0.0 |
0.2 |
GO:0006695 |
cholesterol biosynthetic process(GO:0006695) |
| 0.0 |
0.6 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.0 |
0.1 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
2.2 |
GO:0051439 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.0 |
0.2 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.2 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.0 |
0.2 |
GO:0034620 |
cellular response to unfolded protein(GO:0034620) |
| 0.0 |
1.1 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 |
0.2 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.0 |
0.2 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.1 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 |
0.0 |
GO:0071910 |
determination of liver left/right asymmetry(GO:0071910) |
| 0.0 |
0.0 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.0 |
0.2 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.0 |
0.2 |
GO:0001756 |
somitogenesis(GO:0001756) |
| 0.0 |
0.1 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.0 |
0.1 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.0 |
0.9 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.1 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.1 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 |
0.3 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 |
0.9 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.0 |
0.2 |
GO:0043247 |
protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
| 0.0 |
0.2 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) negative regulation by host of viral transcription(GO:0043922) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.0 |
0.0 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.0 |
0.1 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 |
0.1 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.0 |
0.7 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.1 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.4 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.0 |
GO:0044771 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.0 |
0.6 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.3 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.0 |
0.1 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) clathrin-coated pit assembly(GO:1905224) |
| 0.0 |
0.3 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.0 |
0.0 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.0 |
0.1 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.0 |
0.1 |
GO:0044597 |
polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.0 |
0.3 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.0 |
0.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.0 |
0.1 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.1 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.0 |
0.1 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.0 |
0.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.0 |
0.3 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
0.1 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.1 |
GO:0046885 |
regulation of hormone biosynthetic process(GO:0046885) |
| 0.0 |
0.1 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.2 |
GO:0070987 |
error-free translesion synthesis(GO:0070987) |
| 0.0 |
0.9 |
GO:0071349 |
interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.0 |
0.1 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) type I interferon production(GO:0032606) |
| 0.0 |
0.1 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.3 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 |
0.4 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.1 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.0 |
0.3 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 |
0.9 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.1 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 |
0.1 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.0 |
0.6 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.1 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
0.2 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.3 |
GO:0055072 |
iron ion homeostasis(GO:0055072) |
| 0.0 |
0.1 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.0 |
0.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.3 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.1 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.0 |
0.1 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.3 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 |
0.2 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.1 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
0.1 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.2 |
GO:0008207 |
C21-steroid hormone metabolic process(GO:0008207) |
| 0.0 |
0.5 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.0 |
0.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.0 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 |
0.0 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.1 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.3 |
GO:0000731 |
DNA synthesis involved in DNA repair(GO:0000731) |
| 0.0 |
0.0 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.0 |
0.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.1 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
0.2 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.5 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.3 |
GO:0006568 |
tryptophan metabolic process(GO:0006568) |
| 0.0 |
0.4 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.0 |
0.2 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.0 |
0.0 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.0 |
0.1 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.0 |
0.1 |
GO:0060088 |
auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.0 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.0 |
0.4 |
GO:0006101 |
citrate metabolic process(GO:0006101) |
| 0.0 |
0.1 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.0 |
0.1 |
GO:0048298 |
regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 |
0.1 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.1 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.0 |
0.1 |
GO:0007613 |
memory(GO:0007613) |
| 0.0 |
0.1 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.0 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.0 |
0.1 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.0 |
0.2 |
GO:0050732 |
negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 0.0 |
0.2 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 |
0.1 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.0 |
0.1 |
GO:0021846 |
cell proliferation in forebrain(GO:0021846) |
| 0.0 |
0.1 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 |
0.1 |
GO:0046189 |
phenol-containing compound biosynthetic process(GO:0046189) |
| 0.0 |
0.0 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.0 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.1 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.1 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.0 |
0.1 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.0 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
1.5 |
GO:1902749 |
regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.0 |
0.3 |
GO:0090398 |
cellular senescence(GO:0090398) |
| 0.0 |
0.1 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.0 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
0.2 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.5 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 |
0.0 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.0 |
0.1 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.0 |
0.0 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.1 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.3 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
0.1 |
GO:0046174 |
polyol catabolic process(GO:0046174) |
| 0.0 |
0.0 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.0 |
GO:0006282 |
regulation of DNA repair(GO:0006282) |
| 0.0 |
0.1 |
GO:0045076 |
regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.0 |
0.8 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 0.0 |
0.0 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.0 |
0.1 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
1.2 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 |
0.1 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.0 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.1 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
0.2 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 |
0.1 |
GO:0072033 |
renal vesicle formation(GO:0072033) |
| 0.0 |
0.1 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.0 |
0.0 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.0 |
0.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.1 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.0 |
0.0 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.3 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.0 |
0.1 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.2 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 |
0.3 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.0 |
0.0 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.0 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.0 |
0.3 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 |
0.0 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.0 |
0.1 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.1 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.0 |
GO:1904396 |
regulation of neuromuscular junction development(GO:1904396) |
| 0.0 |
0.0 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.0 |
0.0 |
GO:0034763 |
negative regulation of transmembrane transport(GO:0034763) |
| 0.0 |
0.1 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
0.2 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.1 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.0 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.0 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.1 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.0 |
0.7 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 |
0.1 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 |
0.3 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
